Helen Sabzevari, President, Precigen, Inc at INTREXON CORP (XON), sold 4,822 shares at $7.76 ($37K) on 2019-07-01, disclosed to the SEC on 2019-07-02.
Scheduled sale ($37k) by President, Precigen, Inc under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PGEN | SELL | 2023-08-25 | $236K | — | Filing → |
| PGEN | SELL | 2023-08-18 | $185K | — | Filing → |
| PGEN | SELL | 2023-08-11 | $119K | — | Filing → |